METFORMIN

METFORMIN was reported 303369 times

These side effects are most commonly reported by patients taking METFORMIN:

# Side effect Count
0 DIARRHOEA 23425
1 NAUSEA 23351
2 DRUG INEFFECTIVE 19268
3 BLOOD GLUCOSE INCREASED 18748
4 FATIGUE 18242
5 ACUTE KIDNEY INJURY 17717
6 LACTIC ACIDOSIS 17631
7 VOMITING 15929
8 OFF LABEL USE 14478
9 DYSPNOEA 14259
10 DIZZINESS 12895
11 HEADACHE 12711
12 WEIGHT DECREASED 12456
13 PAIN 12275
14 ASTHENIA 11053
15 MALAISE 10863
16 FALL 9886
17 ARTHRALGIA 9378
18 DECREASED APPETITE 9314
19 DEATH 8034
20 PAIN IN EXTREMITY 7924
21 PNEUMONIA 7750
22 COUGH 7527
23 TOXICITY TO VARIOUS AGENTS 7484
24 PRURITUS 7470
25 HYPOGLYCAEMIA 7443
26 RASH 7380
27 ABDOMINAL PAIN 7301
28 HYPOTENSION 7163
29 INJECTION SITE PAIN 6733
30 CONSTIPATION 6724
31 CONDITION AGGRAVATED 6487
32 DRUG INTERACTION 6379
33 PYREXIA 6359
34 METABOLIC ACIDOSIS 6318
35 HYPERTENSION 6302
36 ABDOMINAL PAIN UPPER 6297
37 WEIGHT INCREASED 6230
38 RENAL FAILURE 6043
39 BACK PAIN 5901
40 DEHYDRATION 5828
41 ANXIETY 5722
42 INSOMNIA 5483
43 ABDOMINAL DISCOMFORT 5441
44 CONFUSIONAL STATE 5422
45 URINARY TRACT INFECTION 5392
46 ANAEMIA 5089
47 BLOOD PRESSURE INCREASED 5069
48 DEPRESSION 5043
49 DIABETES MELLITUS 5040
50 PERIPHERAL SWELLING 4980
51 FEELING ABNORMAL 4977
52 GAIT DISTURBANCE 4928
53 PRODUCT DOSE OMISSION ISSUE 4818
54 CHEST PAIN 4805
55 SOMNOLENCE 4663
56 INCORRECT DOSE ADMINISTERED 4640
57 GLYCOSYLATED HAEMOGLOBIN INCREASED 4585
58 MUSCLE SPASMS 4513
59 BLOOD GLUCOSE DECREASED 4504
60 NASOPHARYNGITIS 4474
61 CHRONIC KIDNEY DISEASE 4379
62 ALOPECIA 4145
63 DIABETIC KETOACIDOSIS 4125
64 CEREBROVASCULAR ACCIDENT 4084
65 MYALGIA 4082
66 MYOCARDIAL INFARCTION 4071
67 HYPERKALAEMIA 4016
68 COVID-19 3980
69 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3934
70 DRUG DOSE OMISSION 3807
71 PRODUCT USE IN UNAPPROVED INDICATION 3772
72 OVERDOSE 3692
73 TREMOR 3670
74 HYPERGLYCAEMIA 3607
75 MUSCULAR WEAKNESS 3538
76 MEMORY IMPAIRMENT 3506
77 HYPERHIDROSIS 3503
78 COMPLETED SUICIDE 3481
79 DYSPEPSIA 3434
80 DRUG HYPERSENSITIVITY 3405
81 HYPOAESTHESIA 3395
82 PARAESTHESIA 3371
83 PRODUCT USE ISSUE 3361
84 VISUAL IMPAIRMENT 3310
85 ATRIAL FIBRILLATION 3281
86 OEDEMA PERIPHERAL 3257
87 GENERAL PHYSICAL HEALTH DETERIORATION 3235
88 ABDOMINAL DISTENSION 3214
89 VISION BLURRED 3212
90 ERYTHEMA 3165
91 RENAL IMPAIRMENT 3136
92 LOSS OF CONSCIOUSNESS 3127
93 PSORIASIS 3062
94 JOINT SWELLING 3055
95 ASTHMA 3053
96 INFLUENZA 3036
97 SYNCOPE 2996
98 URTICARIA 2957
99 SEPSIS 2952
100 DIABETES MELLITUS INADEQUATE CONTROL 2951
101 HYPERSENSITIVITY 2945
102 GASTROOESOPHAGEAL REFLUX DISEASE 2906
103 INJECTION SITE HAEMORRHAGE 2879
104 PALPITATIONS 2813
105 PANCREATITIS 2798
106 HEART RATE INCREASED 2718
107 GASTROINTESTINAL DISORDER 2715
108 CHEST DISCOMFORT 2592
109 BLOOD CREATININE INCREASED 2584
110 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2529
111 CARDIAC ARREST 2518
112 HAEMOGLOBIN DECREASED 2518
113 INFECTION 2471
114 SINUSITIS 2469
115 NEUROPATHY PERIPHERAL 2449
116 TYPE 2 DIABETES MELLITUS 2441
117 ARTHRITIS 2433
118 PRODUCT QUALITY ISSUE 2424
119 INTENTIONAL OVERDOSE 2387
120 BALANCE DISORDER 2385
121 GASTROINTESTINAL HAEMORRHAGE 2360
122 INTENTIONAL PRODUCT USE ISSUE 2354
123 RHEUMATOID ARTHRITIS 2348
124 CARDIAC FAILURE 2340
125 CHILLS 2328
126 OROPHARYNGEAL PAIN 2312
127 TACHYCARDIA 2306
128 CATARACT 2275
129 DRY MOUTH 2261
130 INTENTIONAL PRODUCT MISUSE 2259
131 PULMONARY EMBOLISM 2206
132 HYPONATRAEMIA 2203
133 DRUG INTOLERANCE 2147
134 CONTUSION 2134
135 CARDIAC FAILURE CONGESTIVE 2130
136 BLADDER CANCER 2118
137 ILLNESS 2100
138 WHEEZING 2087
139 FLUSHING 2075
140 BLOOD GLUCOSE ABNORMAL 2070
141 DYSPHAGIA 2070
142 UNDERDOSE 2058
143 BRONCHITIS 2048
144 CARDIAC DISORDER 2036
145 SWELLING 2035
146 STRESS 2027
147 SHOCK 1998
148 RESPIRATORY FAILURE 1984
149 MOBILITY DECREASED 1926
150 IMPAIRED GASTRIC EMPTYING 1895
151 MUSCULOSKELETAL STIFFNESS 1889
152 SLEEP DISORDER 1887
153 FLATULENCE 1885
154 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1872
155 PLATELET COUNT DECREASED 1870
156 BRADYCARDIA 1869
157 INJECTION SITE BRUISING 1862
158 RENAL FAILURE ACUTE 1852
159 DYSGEUSIA 1844
160 DRY SKIN 1818
161 INJECTION SITE MASS 1818
162 OSTEOARTHRITIS 1787
163 HEPATIC ENZYME INCREASED 1786
164 BLOOD CHOLESTEROL INCREASED 1779
165 OXYGEN SATURATION DECREASED 1775
166 HOT FLUSH 1767
167 MIGRAINE 1764
168 RHINORRHOEA 1763
169 NEUTROPENIA 1759
170 RHABDOMYOLYSIS 1741
171 THROMBOCYTOPENIA 1738
172 BLOOD PRESSURE DECREASED 1737
173 POLLAKIURIA 1729
174 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1688
175 PRODUCTIVE COUGH 1687
176 INJECTION SITE ERYTHEMA 1684
177 CELLULITIS 1681
178 SEIZURE 1657
179 MATERNAL EXPOSURE DURING PREGNANCY 1648
180 WHITE BLOOD CELL COUNT DECREASED 1643
181 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1638
182 EXPOSURE DURING PREGNANCY 1637
183 HOSPITALISATION 1632
184 HYPOKALAEMIA 1632
185 PANCREATITIS ACUTE 1626
186 EPISTAXIS 1611
187 MUSCULOSKELETAL PAIN 1609
188 NEPHROLITHIASIS 1593
189 MEDICATION ERROR 1589
190 SUICIDE ATTEMPT 1577
191 SKIN EXFOLIATION 1574
192 LOWER RESPIRATORY TRACT INFECTION 1555
193 DISEASE PROGRESSION 1543
194 BLISTER 1537
195 THROMBOSIS 1532
196 VERTIGO 1528
197 FOETAL EXPOSURE DURING PREGNANCY 1519
198 PRODUCT DOSE OMISSION 1507
199 LETHARGY 1502
200 ADVERSE DRUG REACTION 1498
201 NECK PAIN 1469
202 ARTHROPATHY 1456
203 BLOOD PRESSURE SYSTOLIC INCREASED 1456
204 BURNING SENSATION 1451
205 C-REACTIVE PROTEIN INCREASED 1451
206 LUNG DISORDER 1449
207 DYSPNOEA EXERTIONAL 1446
208 INJECTION SITE PRURITUS 1442
209 CHOLELITHIASIS 1415
210 NASAL CONGESTION 1402
211 DYSARTHRIA 1400
212 INFLUENZA LIKE ILLNESS 1393
213 DISCOMFORT 1392
214 FEELING HOT 1387
215 DEVICE ISSUE 1383
216 SWELLING FACE 1377
217 KETOACIDOSIS 1373
218 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1370
219 HALLUCINATION 1365
220 INFUSION RELATED REACTION 1363
221 AMNESIA 1359
222 ACCIDENTAL OVERDOSE 1353
223 HAEMORRHAGE 1351
224 TREATMENT FAILURE 1351
225 TREATMENT NONCOMPLIANCE 1350
226 DYSPHONIA 1347
227 ALANINE AMINOTRANSFERASE INCREASED 1345
228 AGITATION 1344
229 PSORIATIC ARTHROPATHY 1333
230 DYSURIA 1328
231 COMA 1325
232 HAEMATOCHEZIA 1320
233 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1307
234 MALIGNANT NEOPLASM PROGRESSION 1301
235 RENAL DISORDER 1285
236 ACUTE MYOCARDIAL INFARCTION 1284
237 EYE PAIN 1283
238 OEDEMA 1282
239 FUNGAL INFECTION 1279
240 DEEP VEIN THROMBOSIS 1276
241 BLOOD GLUCOSE FLUCTUATION 1264
242 GAIT INABILITY 1259
243 RECTAL HAEMORRHAGE 1259
244 SUICIDAL IDEATION 1248
245 DEPRESSED MOOD 1247
246 INFLAMMATION 1247
247 SEPTIC SHOCK 1245
248 DRUG LEVEL INCREASED 1244
249 EMOTIONAL DISTRESS 1232
250 CONTRAINDICATED PRODUCT ADMINISTERED 1224
251 CORONARY ARTERY DISEASE 1223
252 FLUID RETENTION 1221
253 HAEMATURIA 1220
254 PLEURAL EFFUSION 1218
255 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1217
256 RASH PRURITIC 1208
257 HYPOMAGNESAEMIA 1206
258 THERAPY INTERRUPTED 1199
259 RENAL INJURY 1185
260 ANGINA PECTORIS 1180
261 PULMONARY OEDEMA 1178
262 DEVICE MALFUNCTION 1172
263 HEPATIC STEATOSIS 1168
264 ANGIOEDEMA 1159
265 UPPER RESPIRATORY TRACT INFECTION 1152
266 STOMATITIS 1151
267 CYSTITIS 1141
268 DRUG-INDUCED LIVER INJURY 1139
269 ARRHYTHMIA 1137
270 HERPES ZOSTER 1129
271 NERVOUSNESS 1121
272 HYPOTHYROIDISM 1116
273 PANCYTOPENIA 1107
274 FEBRILE NEUTROPENIA 1089
275 DISTURBANCE IN ATTENTION 1088
276 INJECTION SITE SWELLING 1087
277 SPEECH DISORDER 1083
278 WHITE BLOOD CELL COUNT INCREASED 1073
279 ADVERSE EVENT 1062
280 HYPOPHAGIA 1061
281 WOUND 1058
282 ELECTROCARDIOGRAM QT PROLONGED 1055
283 INJURY 1054
284 HEART RATE DECREASED 1053
285 TRANSIENT ISCHAEMIC ATTACK 1044
286 BONE PAIN 1042
287 TUBULOINTERSTITIAL NEPHRITIS 1041
288 ASPARTATE AMINOTRANSFERASE INCREASED 1039
289 INJECTION SITE NODULE 1039
290 SKIN DISCOLOURATION 1017
291 DISORIENTATION 1005
292 ERUCTATION 1000
293 PRODUCT SUBSTITUTION ISSUE 997
294 URINARY INCONTINENCE 990
295 END STAGE RENAL DISEASE 989
296 HYPOXIA 985
297 BLINDNESS 974
298 DEPRESSED LEVEL OF CONSCIOUSNESS 974
299 NO ADVERSE EVENT 974
300 COGNITIVE DISORDER 973
301 THERAPY CESSATION 969
302 OBESITY 961
303 BLOOD POTASSIUM DECREASED 959
304 DEVICE LEAKAGE 957
305 THERAPEUTIC PRODUCT EFFECT DECREASED 950
306 URINARY RETENTION 948
307 APHASIA 947
308 ILL-DEFINED DISORDER 946
309 TINNITUS 943
310 SWOLLEN TONGUE 940
311 ANAPHYLACTIC REACTION 937
312 HYPOACUSIS 929
313 IMPAIRED HEALING 928
314 SKIN ULCER 919
315 CARDIO-RESPIRATORY ARREST 916
316 OSTEOPOROSIS 915
317 EATING DISORDER 912
318 LIMB INJURY 912
319 BLOOD PRESSURE FLUCTUATION 911
320 NIGHT SWEATS 905
321 THROAT IRRITATION 891
322 HEAD INJURY 887
323 UNEVALUABLE EVENT 885
324 TASTE DISORDER 882
325 DYSSTASIA 879
326 SLEEP APNOEA SYNDROME 876
327 DELIRIUM 872
328 MENTAL STATUS CHANGES 867
329 INJECTION SITE REACTION 862
330 IRRITABILITY 862
331 PRODUCT STORAGE ERROR 855
332 DIVERTICULITIS 854
333 ANURIA 847
334 LOCALISED INFECTION 845
335 THERAPEUTIC RESPONSE DECREASED 844
336 LIP SWELLING 843
337 LIVER DISORDER 843
338 EXTRA DOSE ADMINISTERED 839
339 EYE IRRITATION 837
340 FREQUENT BOWEL MOVEMENTS 836
341 INTESTINAL OBSTRUCTION 827
342 HYPERLACTACIDAEMIA 824
343 LEUKOCYTOSIS 819
344 BLOOD CREATINE PHOSPHOKINASE INCREASED 816
345 SYNOVITIS 811
346 SURGERY 810
347 UNRESPONSIVE TO STIMULI 808
348 NEEDLE ISSUE 807
349 FIBROMYALGIA 805
350 BLOOD TRIGLYCERIDES INCREASED 797
351 LIMB DISCOMFORT 794
352 GASTRITIS 792
353 ECZEMA 789
354 INTERSTITIAL LUNG DISEASE 787
355 DISEASE RECURRENCE 777
356 ROAD TRAFFIC ACCIDENT 777
357 HEPATIC CIRRHOSIS 775
358 FEELING COLD 772
359 MELAENA 772
360 THERAPEUTIC RESPONSE UNEXPECTED 768
361 EYE DISORDER 765
362 HYPOTHERMIA 765
363 ENCEPHALOPATHY 764
364 DRY EYE 758
365 RED BLOOD CELL COUNT DECREASED 758
366 CEREBRAL HAEMORRHAGE 755
367 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 754
368 THIRST 754
369 MOVEMENT DISORDER 751
370 PANCREATIC CARCINOMA 751
371 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 751
372 PULMONARY FIBROSIS 747
373 HAEMOPTYSIS 745
374 COLITIS 744
375 DRUG EFFECT DECREASED 744
376 NIGHTMARE 742
377 INTERNATIONAL NORMALISED RATIO INCREASED 740
378 GLOMERULAR FILTRATION RATE DECREASED 739
379 GASTRIC DISORDER 734
380 SINUS DISORDER 732
381 BLOOD LACTIC ACID INCREASED 730
382 OBSTRUCTIVE AIRWAYS DISORDER 728
383 EYE SWELLING 724
384 PEMPHIGOID 724
385 HYPOCALCAEMIA 720
386 RASH ERYTHEMATOUS 719
387 IRRITABLE BOWEL SYNDROME 718
388 HAEMATEMESIS 717
389 MENTAL DISORDER 717
390 PRODUCT PRESCRIBING ERROR 716
391 NEOPLASM MALIGNANT 714
392 SYSTEMIC LUPUS ERYTHEMATOSUS 712
393 HAEMATOMA 709
394 BLOOD POTASSIUM INCREASED 708
395 THERAPY NON-RESPONDER 708
396 LIVER FUNCTION TEST ABNORMAL 706
397 VISUAL ACUITY REDUCED 705
398 INJECTION SITE EXTRAVASATION 704
399 PRESYNCOPE 704
400 DRUG ABUSE 702
401 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 702
402 CIRCULATORY COLLAPSE 692
403 ACUTE RESPIRATORY FAILURE 691
404 HEMIPARESIS 691
405 BLOOD URINE PRESENT 690
406 HYPERSOMNIA 687
407 DYSKINESIA 685
408 DIABETIC NEUROPATHY 684
409 AGEUSIA 681
410 COLITIS ULCERATIVE 679
411 RESPIRATORY DISTRESS 675
412 SKIN LESION 674
413 INTERVERTEBRAL DISC PROTRUSION 672
414 LIVER INJURY 672
415 ACIDOSIS 670
416 JOINT INJURY 662
417 TACHYPNOEA 662
418 HEPATIC FAILURE 657
419 VITAMIN B12 DEFICIENCY 657
420 RESTLESSNESS 656
421 BREAST CANCER 653
422 OCULAR HYPERAEMIA 653
423 ORTHOSTATIC HYPOTENSION 644
424 HEPATITIS 643
425 BLOOD PRESSURE ABNORMAL 640
426 PALLOR 639
427 JAUNDICE 635
428 SNEEZING 631
429 GLOSSODYNIA 629
430 RETCHING 629
431 AGGRESSION 627
432 CARDIOGENIC SHOCK 627
433 ACCIDENTAL UNDERDOSE 625
434 FEEDING DISORDER 625
435 EAR INFECTION 622
436 RENAL TUBULAR NECROSIS 621
437 UPPER GASTROINTESTINAL HAEMORRHAGE 621
438 PERICARDITIS 620
439 NEURALGIA 618
440 ACCIDENTAL EXPOSURE TO PRODUCT 617
441 ALTERED STATE OF CONSCIOUSNESS 617
442 VIRAL INFECTION 617
443 GOUT 616
444 GLAUCOMA 615
445 SCIATICA 615
446 BODY TEMPERATURE DECREASED 613
447 HEART RATE IRREGULAR 610
448 GASTROENTERITIS 608
449 FULL BLOOD COUNT ABNORMAL 606
450 LIVER FUNCTION TEST INCREASED 606
451 BLOOD SODIUM DECREASED 604
452 FAECES DISCOLOURED 601
453 LACRIMATION INCREASED 601
454 LYMPHADENOPATHY 601
455 BURSITIS 600
456 EPILEPSY 600
457 ERECTILE DYSFUNCTION 598
458 HIP FRACTURE 596
459 INCORRECT DOSE ADMINISTERED BY DEVICE 593
460 PNEUMONIA ASPIRATION 593
461 DIPLOPIA 592
462 RASH MACULAR 592
463 PANIC ATTACK 590
464 DEMENTIA 588
465 RESPIRATORY DISORDER 588
466 HAIR COLOUR CHANGES 585
467 BLOOD UREA INCREASED 584
468 HYPOVOLAEMIA 584
469 NEUTROPHIL COUNT DECREASED 584
470 SKIN DISORDER 584
471 JOINT RANGE OF MOTION DECREASED 581
472 IMPAIRED WORK ABILITY 579
473 PREMATURE BABY 579
474 SUSPECTED SUICIDE 578
475 DRUG EFFECT INCOMPLETE 576
476 INTENTIONAL DOSE OMISSION 574
477 GAMMA-GLUTAMYLTRANSFERASE INCREASED 573
478 INCREASED APPETITE 572
479 CROHN^S DISEASE 569
480 CORONARY ARTERY OCCLUSION 566
481 EYE PRURITUS 566
482 IMPAIRED QUALITY OF LIFE 564
483 RESPIRATORY TRACT CONGESTION 559
484 LEUKOPENIA 558
485 EXPIRED PRODUCT ADMINISTERED 557
486 OSTEOMYELITIS 557
487 RESPIRATORY TRACT INFECTION 557
488 HAEMATOCRIT DECREASED 556
489 POOR QUALITY SLEEP 554
490 HYPOKINESIA 551
491 BLOOD PRESSURE DIASTOLIC DECREASED 550
492 SKIN BURNING SENSATION 550
493 BLOOD IRON DECREASED 549
494 ISCHAEMIC STROKE 549
495 JOINT STIFFNESS 545
496 POLYURIA 545
497 STAPHYLOCOCCAL INFECTION 544
498 ASCITES 543
499 CHROMATURIA 539
500 SINUS CONGESTION 539
501 HAIR TEXTURE ABNORMAL 538
502 ABDOMINAL PAIN LOWER 537
503 HEMIPLEGIA 536
504 NEPHROGENIC ANAEMIA 536
505 SKIN HAEMORRHAGE 535
506 EAR PAIN 534
507 CARDIOVASCULAR DISORDER 532
508 KIDNEY INFECTION 532
509 RIB FRACTURE 531
510 MENTAL IMPAIRMENT 529
511 COORDINATION ABNORMAL 528
512 PROSTATE CANCER 527
513 MIDDLE INSOMNIA 525
514 HUNGER 524
515 ABNORMAL BEHAVIOUR 523
516 GASTRIC ULCER 522
517 WITHDRAWAL SYNDROME 521
518 EJECTION FRACTION DECREASED 520
519 PERICARDIAL EFFUSION 519
520 SOPOR 519
521 ORAL PAIN 518
522 PROCEDURAL PAIN 517
523 BACK INJURY 515
524 NODULE 513
525 ACNE 512
526 MULTIPLE SCLEROSIS RELAPSE 512
527 PAIN IN JAW 512
528 SENSORY LOSS 512
529 EOSINOPHILIA 511
530 HYPOGLYCAEMIC COMA 511
531 HAEMORRHOIDS 508
532 HYPERLIPIDAEMIA 508
533 PSYCHOLOGICAL TRAUMA 508
534 TOOTHACHE 508
535 ANGER 507
536 BLOOD ALKALINE PHOSPHATASE INCREASED 506
537 COLD SWEAT 504
538 ELECTROLYTE IMBALANCE 502
539 VAGINAL HAEMORRHAGE 502
540 PRODUCT DOSE OMISSION IN ERROR 499
541 PULMONARY HYPERTENSION 497
542 CANDIDA INFECTION 496
543 CRYING 495
544 UROSEPSIS 495
545 CEREBRAL INFARCTION 494
546 CARPAL TUNNEL SYNDROME 492
547 HERNIA 492
548 ARTERIOSCLEROSIS 489
549 PULMONARY MASS 488
550 NOCTURIA 487
551 HALLUCINATION, VISUAL 485
552 PRURITUS GENERALISED 484
553 VENTRICULAR TACHYCARDIA 484
554 SEASONAL ALLERGY 483
555 ARTERIOSCLEROSIS CORONARY ARTERY 479
556 HAEMODYNAMIC INSTABILITY 479
557 BLOOD BILIRUBIN INCREASED 477
558 BASAL CELL CARCINOMA 476
559 MOTOR DYSFUNCTION 475
560 SINUS TACHYCARDIA 474
561 DIABETIC METABOLIC DECOMPENSATION 473
562 DRUG LEVEL ABOVE THERAPEUTIC 473
563 VASCULITIS 472
564 HEPATOTOXICITY 471
565 ABNORMAL LOSS OF WEIGHT 468
566 PRODUCT ADMINISTRATION ERROR 468
567 HAIR DISORDER 467
568 THROAT TIGHTNESS 467
569 PSYCHOTIC DISORDER 466
570 CHOLECYSTITIS 464
571 MUSCULOSKELETAL CHEST PAIN 464
572 FOURNIER^S GANGRENE 463
573 PROTEINURIA 463
574 GASTROENTERITIS VIRAL 460
575 BLOOD MAGNESIUM DECREASED 458
576 EYE HAEMORRHAGE 457
577 HYPERCHOLESTEROLAEMIA 457
578 LABORATORY TEST ABNORMAL 455
579 METASTASES TO LIVER 455
580 FOOT FRACTURE 454
581 MOOD ALTERED 454
582 MITRAL VALVE INCOMPETENCE 453
583 DRUG ADMINISTRATION ERROR 452
584 COAGULOPATHY 451
585 MADAROSIS 451
586 THERAPEUTIC RESPONSE SHORTENED 450
587 MYOPATHY 449
588 PNEUMONITIS 448
589 ABNORMAL DREAMS 447
590 CHOKING 446
591 INJECTION SITE RASH 446
592 DRUG DEPENDENCE 444
593 ARTERIAL OCCLUSIVE DISEASE 442
594 PEMPHIGUS 441
595 RALES 440
596 FEMUR FRACTURE 439
597 PRODUCT ODOUR ABNORMAL 438
598 AFFECT LABILITY 437
599 DRUG WITHDRAWAL SYNDROME 437
600 CHOLESTASIS 436
601 MYOCARDIAL ISCHAEMIA 436
602 ANHEDONIA 434
603 BRONCHIECTASIS 433
604 LUNG NEOPLASM MALIGNANT 433
605 GANGRENE 431
606 MUCOSAL INFLAMMATION 431
607 FOLLICULITIS 428
608 DEAFNESS 426
609 HAEMODIALYSIS 426
610 LIPASE INCREASED 424
611 TRANSAMINASES INCREASED 422
612 RASH GENERALISED 420
613 WOUND INFECTION 420
614 FEAR 419
615 PRESCRIBED UNDERDOSE 419
616 GALLBLADDER DISORDER 418
617 RASH MACULO-PAPULAR 418
618 RESTLESS LEGS SYNDROME 418
619 FLANK PAIN 417
620 FEELING JITTERY 416
621 PRESCRIBED OVERDOSE 415
622 WRONG TECHNIQUE IN DRUG USAGE PROCESS 415
623 ANAL INCONTINENCE 413
624 DERMATITIS ATOPIC 413
625 BACK DISORDER 410
626 MUSCULOSKELETAL DISCOMFORT 410
627 ABSCESS 408
628 BODY TEMPERATURE INCREASED 408
629 RED BLOOD CELL SEDIMENTATION RATE INCREASED 408
630 HEPATIC FUNCTION ABNORMAL 407
631 MUSCLE SPASTICITY 407
632 GASTROINTESTINAL HYPOMOTILITY 404
633 HAND DEFORMITY 404
634 ROTATOR CUFF SYNDROME 404
635 BLOOD COUNT ABNORMAL 403
636 NEPHROPATHY 403
637 BODY HEIGHT DECREASED 402
638 PARKINSONISM 402
639 PREMATURE DELIVERY 401
640 MUSCLE TWITCHING 400
641 PLASMA CELL MYELOMA 400
642 INJECTION SITE URTICARIA 399
643 NEOPLASM PROGRESSION 399
644 UPPER LIMB FRACTURE 399
645 ANKLE FRACTURE 398
646 HEPATIC CYTOLYSIS 398
647 HYPERCALCAEMIA 397
648 PHARYNGITIS 397
649 ABASIA 396
650 DIABETIC RETINOPATHY 396
651 PAIN OF SKIN 394
652 CARDIOMYOPATHY 393
653 ULCER 392
654 TOOTH DISORDER 391
655 COVID-19 PNEUMONIA 390
656 CARDIAC MURMUR 389
657 NERVOUS SYSTEM DISORDER 389
658 RESPIRATORY ARREST 389
659 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 388
660 ACUTE CORONARY SYNDROME 387
661 MICTURITION URGENCY 387
662 MUSCLE ATROPHY 387
663 HIATUS HERNIA 386
664 KNEE ARTHROPLASTY 386
665 MULTIPLE SCLEROSIS 386
666 NEUTROPHIL COUNT INCREASED 385
667 LOCAL SWELLING 381
668 SPUTUM DISCOLOURED 379
669 RHINITIS 377
670 HYPERTENSIVE CRISIS 376
671 ABORTION SPONTANEOUS 375
672 MASS 375
673 ACUTE RESPIRATORY DISTRESS SYNDROME 372
674 BLINDNESS UNILATERAL 372
675 RENAL CYST 372
676 TOOTH INFECTION 372
677 INCORRECT PRODUCT ADMINISTRATION DURATION 371
678 PROSTATIC SPECIFIC ANTIGEN INCREASED 371
679 SEDATION 371
680 HALLUCINATION, AUDITORY 370
681 CARDIOMEGALY 368
682 HEAD DISCOMFORT 367
683 EXOSTOSIS 366
684 HYPERTHYROIDISM 366
685 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 366
686 WEIGHT FLUCTUATION 366
687 DRUG DOSE OMISSION BY DEVICE 365
688 PARKINSON^S DISEASE 365
689 FULL BLOOD COUNT DECREASED 364
690 LEFT VENTRICULAR DYSFUNCTION 363
691 SKIN FISSURES 363
692 RASH PAPULAR 362
693 THYROID DISORDER 362
694 INCORRECT DRUG ADMINISTRATION DURATION 361
695 PAROSMIA 360
696 HYPOVOLAEMIC SHOCK 359
697 OLIGURIA 358
698 PERIPHERAL VENOUS DISEASE 358
699 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 357
700 MOOD SWINGS 357
701 IRON DEFICIENCY ANAEMIA 356
702 TENDONITIS 356
703 BLEPHAROSPASM 354
704 RENAL PAIN 353
705 SKIN IRRITATION 353
706 DECREASED ACTIVITY 352
707 PULMONARY CONGESTION 350
708 NEUROLOGICAL SYMPTOM 349
709 PERIPHERAL COLDNESS 349
710 PHOTOPHOBIA 348
711 PERSONALITY DISORDER 347
712 SUBDURAL HAEMATOMA 346
713 DRUG PRESCRIBING ERROR 344
714 ONYCHOMYCOSIS 344
715 NAIL DISORDER 343
716 C-REACTIVE PROTEIN ABNORMAL 342
717 ONYCHOMADESIS 341
718 VENTRICULAR FIBRILLATION 341
719 LOWER LIMB FRACTURE 340
720 CONVULSION 338
721 SENSORY DISTURBANCE 338
722 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 337
723 INJURY ASSOCIATED WITH DEVICE 337
724 LYMPHOCYTE COUNT DECREASED 336
725 MUSCLE INJURY 335
726 BACTERIAL INFECTION 334
727 MUSCLE TIGHTNESS 334
728 CYST 333
729 DRUG ERUPTION 333
730 DYSLIPIDAEMIA 333
731 INTENTIONAL DEVICE MISUSE 333
732 PRODUCT AVAILABILITY ISSUE 333
733 CLOSTRIDIUM DIFFICILE INFECTION 332
734 ILEUS 332
735 PRODUCT DISPENSING ERROR 332
736 ATRIOVENTRICULAR BLOCK 331
737 BRAIN FOG 330
738 ACUTE HEPATIC FAILURE 329
739 ELECTROCARDIOGRAM ABNORMAL 328
740 GINGIVAL PAIN 328
741 DISTRIBUTIVE SHOCK 327
742 PHOTOSENSITIVITY REACTION 327
743 DELUSION 324
744 POST PROCEDURAL COMPLICATION 324
745 THINKING ABNORMAL 324
746 VITAMIN D DEFICIENCY 324
747 INTERNAL HAEMORRHAGE 323
748 SINUS BRADYCARDIA 323
749 DIZZINESS POSTURAL 322
750 MALNUTRITION 321
751 PLATELET COUNT INCREASED 321
752 GENERALISED TONIC-CLONIC SEIZURE 320
753 INCORRECT PRODUCT STORAGE 320
754 INSURANCE ISSUE 320
755 HYPOAESTHESIA ORAL 319
756 PRODUCT PHYSICAL ISSUE 319
757 RESPIRATORY RATE INCREASED 319
758 SCAR 319
759 URINE OUTPUT DECREASED 319
760 EMOTIONAL DISORDER 315
761 SPINAL FRACTURE 315
762 DEVICE DELIVERY SYSTEM ISSUE 313
763 PYELONEPHRITIS 313
764 GLUCOSE TOLERANCE IMPAIRED 312
765 MYOCARDITIS 312
766 NERVE COMPRESSION 312
767 SCHIZOPHRENIA 312
768 MUSCULOSKELETAL DISORDER 310
769 ORAL CANDIDIASIS 310
770 SECRETION DISCHARGE 310
771 BLINDNESS TRANSIENT 309
772 BONE DISORDER 309
773 OVERWEIGHT 309
774 FORCED EXPIRATORY VOLUME DECREASED 308
775 MYOSITIS 308
776 SEROTONIN SYNDROME 308
777 GRIP STRENGTH DECREASED 307
778 POTENTIATING DRUG INTERACTION 306
779 SKIN LACERATION 306
780 ADJUSTMENT DISORDER 304
781 APPETITE DISORDER 303
782 OSTEOPENIA 303
783 SMALL INTESTINAL OBSTRUCTION 303
784 INCONTINENCE 302
785 LIP DRY 302
786 TENDERNESS 302
787 INFUSION SITE PAIN 301
788 LIGAMENT SPRAIN 301
789 SKIN CANCER 301
790 APHONIA 300
791 HELICOBACTER INFECTION 300
792 MALIGNANT MELANOMA 300
793 CAROTID ARTERY THROMBOSIS 299
794 SARS-COV-2 TEST POSITIVE 299
795 BLOOD PRESSURE DIASTOLIC ABNORMAL 298
796 COLON CANCER 298
797 SPINAL PAIN 298
798 ANAPHYLACTIC SHOCK 297
799 NERVE INJURY 297
800 TOE AMPUTATION 297
801 IMMUNODEFICIENCY 296
802 TOOTH ABSCESS 296
803 HYPERPARATHYROIDISM SECONDARY 295
804 MULTI-ORGAN FAILURE 295
805 DIALYSIS 294
806 VENTRICULAR EXTRASYSTOLES 294
807 MOUTH ULCERATION 293
808 TROPONIN INCREASED 292
809 METASTASES TO BONE 291
810 NEUROLOGIC NEGLECT SYNDROME 291
811 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 291
812 SPLENOMEGALY 291
813 PANCREATIC CARCINOMA METASTATIC 290
814 ATRIOVENTRICULAR BLOCK COMPLETE 289
815 HEPATOCELLULAR INJURY 288
816 BLOOD TEST ABNORMAL 287
817 INTERVERTEBRAL DISC DEGENERATION 286
818 PARAESTHESIA ORAL 286
819 PHARYNGEAL OEDEMA 286
820 ACTIVITIES OF DAILY LIVING IMPAIRED 284
821 DERMATITIS 283
822 HEPATOMEGALY 283
823 AGRANULOCYTOSIS 282
824 PULMONARY ALVEOLAR HAEMORRHAGE 282
825 GENERALISED OEDEMA 281
826 POLYP 281
827 LARGE INTESTINE POLYP 280
828 PRODUCT TASTE ABNORMAL 280
829 TRICUSPID VALVE INCOMPETENCE 280
830 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 279
831 ANOSMIA 277
832 NEOPLASM 277
833 SALIVARY HYPERSECRETION 277
834 FACET JOINT SYNDROME 276
835 TOOTH FRACTURE 276
836 ATRIAL FLUTTER 275
837 DEVICE DISLOCATION 275
838 FACE OEDEMA 275
839 FINGER DEFORMITY 275
840 MUSCLE RIGIDITY 275
841 ADRENAL INSUFFICIENCY 274
842 ASPIRATION 274
843 EXERCISE TOLERANCE DECREASED 274
844 INABILITY TO AFFORD MEDICATION 274
845 SUBARACHNOID HAEMORRHAGE 274
846 GASTROINTESTINAL PAIN 273
847 LIVE BIRTH 273
848 SUPRAVENTRICULAR TACHYCARDIA 273
849 PULSELESS ELECTRICAL ACTIVITY 272
850 METASTASES TO LUNG 271
851 REBOUND ACID HYPERSECRETION 271
852 PRODUCT ADHESION ISSUE 269
853 FOOT DEFORMITY 268
854 POLYNEUROPATHY 268
855 SLUGGISHNESS 268
856 SPINAL OSTEOARTHRITIS 267
857 ADVERSE REACTION 266
858 DRUG DISPENSING ERROR 264
859 FAECES SOFT 264
860 RESPIRATORY SYMPTOM 264
861 BONE DENSITY DECREASED 263
862 BREAST CANCER STAGE III 263
863 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 261
864 INJECTION SITE DISCOMFORT 261
865 ATELECTASIS 260
866 DUODENAL ULCER 260
867 HAEMORRHAGE INTRACRANIAL 260
868 OSTEONECROSIS OF JAW 260
869 BLOOD LACTATE DEHYDROGENASE INCREASED 259
870 LARYNGITIS 259
871 LEFT VENTRICULAR HYPERTROPHY 259
872 RETINAL DETACHMENT 259
873 SCAB 259
874 DUODENAL ULCER PERFORATION 258
875 PARANOIA 257
876 SKIN INFECTION 257
877 LOWER GASTROINTESTINAL HAEMORRHAGE 256
878 OESOPHAGITIS 255
879 ORAL HERPES 255
880 POISONING 255
881 POOR VENOUS ACCESS 255
882 DIABETIC FOOT 254
883 INITIAL INSOMNIA 254
884 NORMOCHROMIC NORMOCYTIC ANAEMIA 254
885 PARALYSIS 254
886 ANGINA UNSTABLE 252
887 DEVICE BREAKAGE 252
888 NEPHROPATHY TOXIC 252
889 APPLICATION SITE PAIN 251
890 BEDRIDDEN 251
891 TARDIVE DYSKINESIA 251
892 CHOLECYSTECTOMY 250
893 IMMUNE-MEDIATED MYOSITIS 249
894 APATHY 248
895 GLYCOSYLATED HAEMOGLOBIN DECREASED 246
896 INTENTIONAL SELF-INJURY 246
897 LUNG INFECTION 246
898 MANIA 246
899 POLYDIPSIA 246
900 RED CELL DISTRIBUTION WIDTH INCREASED 246
901 BLOOD BICARBONATE DECREASED 245
902 NEUROLEPTIC MALIGNANT SYNDROME 245
903 ORAL DISCOMFORT 245
904 ANION GAP INCREASED 244
905 EYE INFECTION 244
906 HYPOPNOEA 244
907 METABOLIC DISORDER 244
908 HYPOPHOSPHATAEMIA 243
909 SKIN REACTION 243
910 ECONOMIC PROBLEM 242
911 MACULAR DEGENERATION 242
912 SUDDEN DEATH 242
913 HAEMOLYTIC ANAEMIA 241
914 INJECTION SITE WARMTH 241
915 SCRATCH 241
916 BLOOD PRESSURE INADEQUATELY CONTROLLED 240
917 BLOOD PRESSURE SYSTOLIC ABNORMAL 240
918 FACIAL PARALYSIS 240
919 PRODUCT USE COMPLAINT 240
920 PULMONARY VASCULITIS 240
921 HAEMORRHAGIC STROKE 239
922 NEURITIS 239
923 BRAIN INJURY 238
924 EMPHYSEMA 238
925 GROIN PAIN 238
926 INJECTION SITE DISCOLOURATION 238
927 MEDICATION RESIDUE PRESENT 238
928 SPINAL DISORDER 238
929 RHEUMATIC FEVER 237
930 IMMUNE SYSTEM DISORDER 236
931 MULTIPLE FRACTURES 236
932 TOXIC ENCEPHALOPATHY 236
933 VITAMIN B12 DECREASED 236
934 FRACTURE 235
935 HIDRADENITIS 235
936 VITAMIN D DECREASED 235
937 VITREOUS FLOATERS 235
938 DISABILITY 234
939 FRUSTRATION TOLERANCE DECREASED 234
940 NECROTISING FASCIITIS 234
941 TENDON RUPTURE 234
942 BREATH SOUNDS ABNORMAL 233
943 PRODUCT ADMINISTRATION INTERRUPTED 233
944 TRANSFUSION 233
945 INSULIN RESISTANCE 232
946 SHOCK HAEMORRHAGIC 232
947 WOUND COMPLICATION 232
948 BLOOD THYROID STIMULATING HORMONE INCREASED 231
949 HYPERTRIGLYCERIDAEMIA 231
950 POISONING DELIBERATE 229
951 RESPIRATION ABNORMAL 229
952 DRUG RESISTANCE 228
953 FACIAL PAIN 228
954 PRODUCT PRESCRIBING ISSUE 228
955 CORONARY ARTERY STENOSIS 227
956 CYANOSIS 227
957 ATAXIA 226
958 GINGIVAL BLEEDING 225
959 QUALITY OF LIFE DECREASED 225
960 RENAL CANCER 225
961 INTESTINAL ISCHAEMIA 223
962 HIP ARTHROPLASTY 222
963 MULTIPLE ALLERGIES 222
964 BLOOD CHOLESTEROL ABNORMAL 221
965 DERMATITIS CONTACT 221
966 LOW DENSITY LIPOPROTEIN INCREASED 221
967 OCULAR DISCOMFORT 221
968 PNEUMOTHORAX 221
969 APPLICATION SITE ERYTHEMA 220
970 BLOOD CALCIUM DECREASED 220
971 CARDIAC FAILURE CHRONIC 220
972 DIVERTICULUM 220
973 PSYCHOMOTOR HYPERACTIVITY 220
974 BACTERAEMIA 219
975 HAEMORRHAGIC ANAEMIA 219
976 HEPATIC ENCEPHALOPATHY 219
977 WRIST FRACTURE 219
978 DEVICE FAILURE 216
979 DEVICE MECHANICAL ISSUE 216
980 TOOTH LOSS 216
981 CYTOKINE RELEASE SYNDROME 215
982 MENISCUS INJURY 215
983 DEVICE USE ISSUE 214
984 EXTRAPYRAMIDAL DISORDER 214
985 INJECTION SITE INDURATION 214
986 PULMONARY THROMBOSIS 214
987 DEVICE DIFFICULT TO USE 213
988 DRY THROAT 213
989 GASTROINTESTINAL INFECTION 213
990 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 213
991 PELVIC PAIN 213
992 ATRIOVENTRICULAR BLOCK FIRST DEGREE 212
993 BUNDLE BRANCH BLOCK LEFT 212
994 COELIAC DISEASE 212
995 HICCUPS 212
996 JOINT DISLOCATION 212
997 BOWEL MOVEMENT IRREGULARITY 211
998 CONCOMITANT DISEASE AGGRAVATED 211
999 DECUBITUS ULCER 211